Doneddu, Pietro Emiliano
,
Bianchi, Elisa
Cocito, Dario
Manganelli, Fiore
Fazio, Raffaella
Filosto, Massimiliano
Beghi, Ettore
Mazzeo, Anna
Cosentino, Giuseppe
Cortese, Andrea
Jann, Stefano
Clerici, Angelo Maurizio
Antonini, Giovanni
Siciliano, Gabriele
Marfia, Girolama Alessandra
Briani, Chiara
Lauria, Giuseppe
Rosso, Tiziana
Cavaletti, Guido
Carpo, Marinella
Benedetti, Luana
Schenone, Angelo
Liberatore, Giuseppe
Peci, Erdita
Spina, Emanuele
Tronci, Stefano
Cotti Piccinelli, Stefano
Toscano, Antonio
Gentile, Luca
Piccolo, Laura
Leonardi, Luca
Mataluni, Giorgia
Ruiz, Marta
Sabatelli, Mario
Santoro, Lucio
Nobile-Orazio, Eduardo
Funding for this research was provided by:
Regione Lombardia
Kedrion Biopharma
CSL Behring
Humanitas Clinical and Research Institute
GBS-CIDP Foundation International
Article History
Received: 8 March 2020
Revised: 11 May 2020
Accepted: 13 May 2020
First Online: 19 May 2020
Compliance with ethical standards
:
: Pietro Emiliano Doneddu has received travel grants to attend scientific meetings from CSL Behring and Kedrion. Dario Cocito has received honoraria for lecturing fromShire, CSL Behring, and Kedrion and travel grants to attend scientific meeting from Shire, Kedrion, and CSL Behring. Fiore Manganelli reports personal fees for scientific events from CSL Behring and has received travel grants to attend scientific meetings from CSL Behring and Kedrion. Raffaella Fazio has served on scientific advisory boards for CSL Behring and has received travel grants from Kedrion and CSL Behring to attend scientific meeting. Chiara Briani has served on scientific advisory boards for Pfizer, Alnylam, and Akcea, and has received travel grants from Kedrion and CSL Behring to attend scientific meeting. Massimiliano Filosto has served on scientific advisory boards for CSL Behring and has received travel grants from Kedrion, Baxter and CSL Behring to attend scientific meeting. Stefano Jann has received research grants from Grifols, outside this work, and travel grants from Grifols and Kedrion. Anna Mazzeo has received travel grants from Kedrion and CSL Behring to attend scientific meeting. Giuseppe Cosentino has received travel grants to attend scientific meetings from CSL Behring and Kedrion. Andrea Cortese has received travel grants to attend scientific meetings from Kedrion. Marinella Carpo has received travel grants to attend scientific meetings from Kedrion. Guido Cavaletti has received honoraria for lecturing and travel grants to attend scientific meetings from Kedrion. Ettore Beghi reports grants from UCB-Pharma, grants from Shire, grants from EISAI, personal fees from Viropharma, grants from Italian Ministry of Health, grants from Fondazione Borgonovo, grants from Associazione IDIC 15 and grants from European Union, outside the submitted work. Giuseppe Liberatore has received travel grants to attend scientific meetings from CSL Behring and Kedrion. Lucio Santoro reports personal fees for scientific events from CSL Behring and has received travel grants to attend scientific meetings from CSL Behring and Kedrion. Erdita Peci has received travel grants to attend scientific meetings from CSL Behring. Eduardo Nobile Orazio reports personal fees for Advisory or Scientific Board from Kedrion, Italy, Baxter, Italy, Novartis, Switzerland, CSL-Behring, Italy, Astellas, the Netherlands, outside the submitted work and travel grants to attend Scientific Meeting from Baxter, Grifols, Kedrion, and Novartis, Italy. The other authors declare no conflict of interest.
: The study was approved by the Ethical Committee of each participating center.
: Written informed consent was obtained from all participants at enrollment.